Combine MEK inhibition with PI3K/mTOR inhibition exert inhibitory tumor growth effect on KRAS and PIK3CA mutation CRC xenografts due to reduced expression of VEGF and matrix metallopeptidase-9
Year: 2014
Type: article
Source: Tumor Biology
Authors: Jifu E, Junjie Xing, Haifeng Gong, Jian He, Wei Zhang
Institutions: Second Military Medical University, Changhai Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: MEK inhibition, PI3K/mTOR inhibition, KRAS mutation, PIK3CA mutation, colorectal cancer, selumetinib, BEZ235, cetuximab, combination therapy, angiogenesis inhibition, vascular endothelial growth factor, MMP-9, ERK1/2 phosphorylation, Akt phosphorylation, HCT116 xenograft, cetuximab resistance
Open Access status: closed
OpenAlex ID: W2047946511
